FDA Issues Draft Guidance Recognizing the Role of Real-World Evidence in Learning More about Populations Underrepresented in Clinical Trials for Drugs and Biological Products
By: Ulka Campbell, Head of Scientific Strategy, Aetion Of the many potential use cases for real-world data (RWD) [...]
How Quality Research Initiatives are Advancing Precision Oncology and Value-Based Care
Precision medicine and value-based care are buzzwords used over the last two decades. At inception, these principles were seen [...]
Podcast Q&A: Improving the Representativeness of Research
This podcast segment features the Q&A from Cardinal Health's March 23, 2023 webinar with HealthEconomics.Com. Join Dr. Bruce Feinberg, Dr. [...]
Get to Know R-S-S (Regulatory Scientific and Health Solutions)
Supplier Spotlight® highlights the unique skills and services offered by organizations that are part of our CONNECTED COMMUNITY™. [...]
Real-World Data Can Bring Value to Life Sciences Companies Operating in a Value-Based World
The healthcare industry -- from providers and health systems to payers -- is increasingly adopting [...]
Podcast Q&A: Making HEOR More Accessible to Patients
This podcast segment features the Q&A from OPEN Health's October 13, 2022 webinar and features an expert panel, including Danielle [...]
Podcast Q&A: An Introduction to Infectious Disease Modeling
This podcast segment from ICON's September 29, 2022 webinar features the Q&A with Marija Zivkovic-Gojovic, Richard Pitman, and Pragya Khurana [...]
Podcast Q&A: Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations
This podcast segment from Self Care Catalysts' June 29, 2022 webinar features the Q&A with Renee Willmon, MSc, Senior Director, [...]
Real-World Data for Mental Health – Understanding Outcomes and Unlocking Pathways to More Precise Treatments
OM1 was founded by a team dedicated to the belief that participating in value-based healthcare requires a much more complete [...]
Podcast Q&A: FDA Guidance Documents: Shaping the Future of RWD Curation and RWE Innovation
This podcast segment features the Q&A from IQVIA's May 25, 2022 webinar hosted IQVIA experts Raina Olexa, Senior Principal Scientist [...]
Podcast Q&A: Cracking the Code: When and How to Validate ICD Algorithms for RWE
This podcast segment features the Q&A from PHAR LLC's webinar from April 12, 2022 which featured experts from PHAR, Genentech, [...]
Podcast Q&A: Optimizing Real-World Evidence for Maternal and Neonatal Outcomes
This podcast segment features the Q&A from HealthCore's webinar from April 9, 2022 which featured an expert panel of health [...]
Foundation of Sand
The last decade has seen an explosion of interest in and production of real world evidence (RWE). But I’m afraid there is a day of reckoning approaching.
Delivering Real World Data-Driven Insights: An Executive Interview with Wendy Shusko and Jason Drenning
Delivering Real World Data-Driven Insights:An Executive Interview with Wendy Shusko and Jason Drenning Wendy Shusko, President and CEO and Jason [...]
Actu-Real Supplier Spotlight
Supplier Spotlight® highlights the unique skill sets and service offerings of our vast supplier network. Below is an interview with [...]
Redbird RWE Develops System Making RWE Regulations More Navigable
Too much precious time is lost trying to navigate the complex and often convoluted landscape of real world evidence regulations. [...]
Real-world Data Takes Center Stage in COVID-19 Response: Evidence Accelerator Community Tool Featured in Webinar by DIA
A webinar on "Real-World Data to Inform COVID-19 Response: Collaborating in the COVID-19 Evidence Accelerator" is taking place on Tuesday, [...]
Former FDA Commish Califf: Weighing the Benefits & Risks of the Growing Number of Observational Treatment Assessments
In a recently published JAMA Viewpoint, former FDA Commissioner Robert Califf and colleagues mused about a growing concern about inferring [...]
IQVIA’s Dreyer Stresses Importance of RWE Amid Pandemic
In a recent interview with Managed Healthcare Executive, IQVIA CSO Nancy Dreyer said the COVID-19 pandemic has made the use [...]
Taking Action from RWE Analytics: Use of Health Insights Dataset Reveal Underdiagnosis and Care Gaps in NASH and NAFLD
Excerpt of tHEORetically Speaking blog post sponsored by Veradigm Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic [...]
McClellan Stresses Need for RWE Infrastructure
Duke-Margolis' Mark McClellan tells The Pink Sheet a robust real-world evidence infrastructure is needed, and that RWE studies should be [...]
Pink Sheet Analysis Spotlights COVID-19 Article Debacle
A recent analysis by the Pink Sheet looks at how the retraction of Lancet and New England Journal of Medicine [...]
RCTs vs. RWE? Why Not Both?
Aetion Co-Founder and President Jeremy Rassen in a recent blog post discusses a new paradigm in which randomized controlled trials [...]
Former FDA Chiefs Encourage Collection of RWE
Former Food and Drug Administration chiefs Mark McClellan and Scott Gottlieb urged greater incentives for the collection of real-world evidence [...]
Prieto-Alhambra Talks RWE in Decision-Making During Pandemic
University of Oxford's Daniel Prieto-Alhambra in a recent interview with The Evidence Base discussed the role of real-world evidence amid [...]
